Company / Free Cash Flow
Day One Biopharmaceuticals, Inc. Free Cash Flow History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$104.1M
FY2025
5-year range
-$147.1M / -$48.5M
FY2021-FY2025
Trend
-29.6%
vs FY2024
Sector context
#106 of 192
Health Care
What the data says
At -$104M, Day One Biopharmaceuticals, Inc.'s free cash flow ranks #106 of 192 in the Health Care sector. Improved from -$147M to -$104M over the past 2 years.
Based on SEC 10-K filings.
-$104M in FY2025.
Improved from -$147M to -$104M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#106 of 192 in Health CareTop 55% of 192This company -$104.1M Sector average $474.2M
▼
-121.9% below sector average
Key checks
Key Insights
- In FY2025, free cash flow decreased 29.6% year-over-year.
- Ranks #106 out of 192 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2019.
- Lowest free cash flow in the period was in FY2023.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$104.1M | -29.6% |
| FY2024 | -$80.3M | +45.4% |
| FY2023 | -$147.1M | -33.8% |
| FY2022 | -$109.9M | -126.4% |
| FY2021 | -$48.5M | -257.4% |
| FY2020 | -$13.6M | -200.8% |
| FY2019 | -$4.5M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026